The Hematology/Oncology Conference is moderated by Robert G. Lerner, M.D., Professor of Medicine at New York Medical College.
This conference may include discussion of commercial products and services.
The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Dr. Robert G. Lerner, Cyberounds® Hematology/Oncology moderator, is Professor and Vice Chairman, Department of Medicine and Professor of Pathology at New York Medical College and is board certified in both …hematology and medical oncology. A Phi Beta Kappa graduate of NYU and its medical school, Bob did his postgraduate training at Bellevue, Montefiore Hospital and USC. He is a recipient of an NIH Research Career Development Award and is Chief, Hematology, Westchester County Medical Center. Thromboembolic disease and the control of coagulation are Dr. Lerner's major areas of research interest.
Within the past 12 months, Dr. Lerner has received research/grant support from Sanofi-Aventis and Boehringer Ingelheim, and been on the Speakers Bureau for Eisai, GlaxoSmithKline and Sanofi-Aventis.
Last Update: 2/21/2021
